Stratec SE (0RAR.L)
EUR 28.7
(-8.92%)
EUR 28.7
(-8.92%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 107.83 Million EUR | 67.24% |
| 2022 | 64.48 Million EUR | 69.19% |
| 2021 | 38.11 Million EUR | -47.08% |
| 2020 | 72.01 Million EUR | 2.08% |
| 2019 | 70.55 Million EUR | 54.32% |
| 2018 | 45.71 Million EUR | 19.16% |
| 2017 | 38.36 Million EUR | -22.22% |
| 2016 | 49.32 Million EUR | 202.19% |
| 2015 | -48.27 Million EUR | -21.58% |
| 2014 | -39.7 Million EUR | -225.52% |
| 2013 | -12.19 Million EUR | -167.07% |
| 2012 | -4.56 Million EUR | 76.64% |
| 2011 | -19.54 Million EUR | -47.84% |
| 2010 | -13.22 Million EUR | 37.59% |
| 2009 | -21.18 Million EUR | -10.3% |
| 2008 | -19.2 Million EUR | 3.4% |
| 2007 | -19.88 Million EUR | -65.82% |
| 2006 | -11.99 Million EUR | -52.99% |
| 2005 | -7.83 Million EUR | -768.27% |
| 2004 | 1.17 Million EUR | -72.01% |
| 2003 | 4.19 Million EUR | 141660.79% |
| 2002 | 2956.00 EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 119.42 Million EUR | -0.4% |
| 2024 Q2 | 119.9 Million EUR | -2.46% |
| 2024 Q1 | 122.93 Million EUR | 14.0% |
| 2023 Q3 | 131.8 Million EUR | 40.62% |
| 2023 FY | 107.83 Million EUR | 67.24% |
| 2023 Q1 | 77.98 Million EUR | 20.94% |
| 2023 Q2 | 93.73 Million EUR | 20.19% |
| 2023 Q4 | 107.83 Million EUR | -18.18% |
| 2022 FY | 64.48 Million EUR | 69.19% |
| 2022 Q1 | 54.98 Million EUR | 44.26% |
| 2022 Q2 | 51.9 Million EUR | -5.59% |
| 2022 Q3 | 69.79 Million EUR | 34.45% |
| 2022 Q4 | 64.48 Million EUR | -7.61% |
| 2021 Q1 | 75.69 Million EUR | 5.1% |
| 2021 FY | 38.11 Million EUR | -47.08% |
| 2021 Q2 | 72.74 Million EUR | -3.89% |
| 2021 Q3 | 61.89 Million EUR | -14.91% |
| 2021 Q4 | 38.11 Million EUR | -38.43% |
| 2020 FY | 72.01 Million EUR | 2.08% |
| 2020 Q1 | 84.09 Million EUR | 19.2% |
| 2020 Q2 | 84.61 Million EUR | 0.61% |
| 2020 Q3 | 76.01 Million EUR | -10.17% |
| 2020 Q4 | 72.01 Million EUR | -5.25% |
| 2019 FY | 70.55 Million EUR | 54.32% |
| 2019 Q3 | 86.07 Million EUR | 15.12% |
| 2019 Q2 | 74.76 Million EUR | 20.02% |
| 2019 Q4 | 70.55 Million EUR | -18.03% |
| 2019 Q1 | 62.29 Million EUR | 36.26% |
| 2018 Q1 | 40.4 Million EUR | 5.3% |
| 2018 FY | 45.71 Million EUR | 19.16% |
| 2018 Q4 | 45.71 Million EUR | 3.5% |
| 2018 Q2 | 42.75 Million EUR | 5.83% |
| 2018 Q3 | 44.17 Million EUR | 3.3% |
| 2017 Q1 | 40.22 Million EUR | -18.46% |
| 2017 FY | 38.36 Million EUR | -22.22% |
| 2017 Q4 | 38.36 Million EUR | -11.95% |
| 2017 Q3 | 43.57 Million EUR | -15.19% |
| 2017 Q2 | 51.37 Million EUR | 27.73% |
| 2016 Q4 | 49.32 Million EUR | -3.12% |
| 2016 Q1 | 57.89 Million EUR | 219.93% |
| 2016 Q2 | 53.34 Million EUR | -7.85% |
| 2016 FY | 49.32 Million EUR | 202.19% |
| 2016 Q3 | 50.91 Million EUR | -4.56% |
| 2015 Q4 | -48.27 Million EUR | 2.42% |
| 2015 Q1 | -50.04 Million EUR | -26.04% |
| 2015 FY | -48.27 Million EUR | -21.58% |
| 2015 Q2 | -43.06 Million EUR | 13.94% |
| 2015 Q3 | -49.46 Million EUR | -14.86% |
| 2014 Q3 | -27.5 Million EUR | -42.24% |
| 2014 FY | -39.7 Million EUR | -225.52% |
| 2014 Q1 | -19.85 Million EUR | -62.81% |
| 2014 Q4 | -39.7 Million EUR | -44.36% |
| 2014 Q2 | -19.33 Million EUR | 2.63% |
| 2013 Q3 | -10.02 Million EUR | -72.07% |
| 2013 Q1 | -10.25 Million EUR | -124.59% |
| 2013 FY | -12.19 Million EUR | -167.07% |
| 2013 Q4 | -12.19 Million EUR | -21.67% |
| 2013 Q2 | -5.82 Million EUR | 43.2% |
| 2012 Q3 | -14.12 Million EUR | 20.01% |
| 2012 Q4 | -4.56 Million EUR | 67.67% |
| 2012 Q2 | -17.65 Million EUR | 30.06% |
| 2012 Q1 | -25.25 Million EUR | -162.91% |
| 2012 FY | -4.56 Million EUR | 76.64% |
| 2011 Q4 | -9.6 Million EUR | 32.22% |
| 2011 Q2 | -11.49 Million EUR | 25.31% |
| 2011 Q3 | -14.17 Million EUR | -23.31% |
| 2011 FY | -19.54 Million EUR | -47.84% |
| 2011 Q1 | -15.38 Million EUR | -195.07% |
| 2010 FY | -13.22 Million EUR | 37.59% |
| 2010 Q1 | -17.36 Million EUR | 18.05% |
| 2010 Q3 | -11.66 Million EUR | 14.67% |
| 2010 Q4 | -5.21 Million EUR | 55.29% |
| 2010 Q2 | -13.66 Million EUR | 21.29% |
| 2009 FY | -21.18 Million EUR | -10.3% |
| 2009 Q4 | -21.18 Million EUR | 0.0% |
| 2008 FY | -19.2 Million EUR | 3.4% |
| 2007 FY | -19.88 Million EUR | -65.82% |
| 2006 FY | -11.99 Million EUR | -52.99% |
| 2005 FY | -7.83 Million EUR | -768.27% |
| 2004 FY | 1.17 Million EUR | -72.01% |
| 2003 FY | 4.19 Million EUR | 141660.79% |
| 2002 FY | 2956.00 EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Cegedim SA | 238.49 Million EUR | 54.784% |
| Guerbet SA | 313.3 Million EUR | 65.581% |
| Nexus AG | 2.81 Million EUR | -3736.322% |
| Bastide Le Confort Médical SA | 333.35 Million EUR | 67.65% |
| Revenio Group Oyj | -2.8 Million EUR | 3951.393% |
| Drägerwerk AG & Co. KGaA | 199.42 Million EUR | 45.926% |
| Sartorius Aktiengesellschaft | 4.89 Billion EUR | 97.799% |
| LNA Santé SA | 810.5 Million EUR | 86.695% |
| Siemens Healthineers AG | -1 Billion EUR | 110.688% |
| Medios AG | -53.89 Million EUR | 300.102% |
| Equasens Société anonyme | 50.84 Million EUR | -112.11% |